Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001663:Bilirubin / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000453:epidemiology; D004977:Ethambutol / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects*; D000637:Transaminases / Q000097:blood
D004977:Ethambutol; D000637:Transaminases; D001663:Bilirubin; D007538:Isoniazid; D012293:Rifampin